Healthcare Trust (HTA) Stock Price Target Raised at Oppenheimer

Healthcare Trust’s (HTA) stock price target was lifted to $37 from $32 at Oppenheimer.
By Kaya Yurieff ,

NEW YORK (TheStreet) -- Healthcare Trust of America's (HTA) - Get Report stock price target was boosted to $37 from $32 at Oppenheimer. The firm has an "outperform" rating on shares of the real estate investment trust.

"The REIT offers a combination of steady internal growth and disciplined external growth, all on an active management platform," the firm wrote in an analyst note.

"Like many REITs, HTA recently took advantage of the wide-open unsecured bond market, upsizing to $350 million (from $200 million initially) a 3.5% 10-year offering," Oppenheimer added.

This terms out debt, lowers the balance outstanding on the credit facility and most importantly puts the company in a position to make additional acquisitions, according to the firm.

Although the stock is not cheap, Oppenheimer continues to favor disciplined and steady growers like Healthcare Trust.

The Scottsdale, AZ-based company acquires, owns and operates medical office buildings.

Shares of Healthcare Trust closed lower by 0.67% to $32.66 on Tuesday.

Separately, TheStreet Ratings Team has a "Buy" rating with a score of B on the stock.

The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, good cash flow from operations, solid stock price performance and growth in earnings per share. 

Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.

You can view the full analysis from the report here: HTA

Loading ...